ArticleBioengineering (Basel, Switzerland)2024

Utilizing a Pathomics Biomarker to Predict the Effectiveness of Bevacizumab in Ovarian Cancer Treatment.

Patrik Gilley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.